Olfactory epithelial lesions induced by various cancer chemotherapeutic agents in mice

Kiyonori Kai1, Hiroshi Satoh, Tetsuyo Kajimura

  • 1Drug Safety Research Laboratory, Daiichi Pharmaceutical Co., Ltd., 1-16-13 Kitakasai, Edogawa-ku, Tokyo 134-8630, Japan. kaikitrx@daiichipharma.co.jp

Toxicologic Pathology
|December 8, 2004
PubMed

Insights

Antitumor drugs targeting microtubules, like paclitaxel, can cause olfactory epithelium apoptosis in mice. High drug distribution in nasal tissues may lead to olfactory lesions.

Area of Science:

  • Toxicology
  • Pharmacology
  • Oncology

Background:

  • Antitumor drugs are crucial in cancer treatment.
  • Potential side effects of chemotherapy on non-target organs require thorough investigation.
  • The olfactory epithelium is a sensitive tissue that may be affected by systemic drug administration.

Purpose of the Study:

  • To compare the toxicity of various antitumor drugs on the olfactory epithelium in mice.
  • To investigate the mechanism of drug-induced cell death in the olfactory epithelium.
  • To assess the drug distribution in nasal tissues following administration.

Main Methods:

  • Intravenous injection of antitumor drugs at 10% lethal dose (LD(10)) in male BALB/c mice.
  • Nasal tissue examination using light microscopy, TUNEL assay, keratin antibody staining, and electron microscopy.
  • Whole-body radioluminography to determine drug disposition in nasal tissues.

Main Results:

  • Antimicrotubule agents (vincristine sulfate, vinblastine sulfate, vindesine sulfate, paclitaxel) induced apoptosis in olfactory epithelial cells, particularly sensory cells.
  • Paclitaxel demonstrated the most significant toxicity among the antimicrotubule agents.
  • Higher paclitaxel concentration was observed in nasal tissues compared to 5-fluorouracil, correlating with olfactory lesions.

Conclusions:

  • Tubulin-targeting antitumor drugs can induce apoptosis in mouse olfactory epithelial cells.
  • High drug distribution within nasal tissues is a potential factor in the development of olfactory lesions.
  • These findings highlight the need to consider olfactory toxicity in chemotherapy regimens.